At issue are allegations that the product caused serious health problems, such as increased risk of blood clots and stroke. MDL 3:09-md-2100-DRH-PMF Yasmin and Yaz Marketing, Sales Practices and Products Liability Litigation (S.D. Ill); JCCP 4608 Yaz, Yasmin and Ocella Contraceptive Cases (L.A. Super. Ct.).
She also is representing cli...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In